Text Size
776 studies found for:    vaccines [CONDITION] OR vaccines [TREATMENT] | Open Studies

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines
Conditions: Immunity to Oral Rotavirus Vaccine;   Immunity to Oral Polio Vaccine;   Shedding of Oral Rotavirus Vaccine
Intervention: Biological: Rotavirus vaccine (Rotarix), oral polio vaccine (Bio-polio), zinc supplement and probiotic supplement (Culturelle)
2 Not yet recruiting IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi.
Conditions: Immunity to Polio Vaccines in Malnourished Infants;   Immunity to Polio Vaccines in Non-malnourished Infants
Intervention: Biological: Injectable polio vaccine and Bivalent oral polio vaccine
3 Unknown † Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults
Conditions: Pneumococcal Vaccines;   HIV;   HIV Infections
Intervention: Biological: Prevenar and Pneumo23
4 Recruiting Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection
Condition: Vaccine Overdose of Undetermined Intent
Interventions: Biological: prophylactic peptide vaccine;   Biological: therapeutic peptide vaccine
5 Recruiting The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age
Conditions: Mortality;   Vaccines
Intervention: Biological: Providing measles vaccine for all children 9-35 months who have not yet received a routine measles vaccine
6 Recruiting Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs
Condition: Vaccine Response Impaired
Intervention: Biological: hepatitis A vaccine
7 Recruiting Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.
Conditions: 13-valent Pneumococcal Vaccine;   Premature Birth;   Immunization;   Safety
Intervention: Biological: 13-valent pneumococcal conjugate vaccine
8 Recruiting Trial of Additional Measles Vaccine to Reduce Child Mortality
Condition: Measles Vaccine
Intervention: Biological: Early measles vaccine
9 Not yet recruiting Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Healthy Adults
Condition: Tuberculosis Vaccines
Interventions: Biological: GSK Biologicals' TB vaccine GSK 692342;   Biological: Placebo
10 Recruiting Therapeutic Vaccine for HIV
Conditions: HIV;   Therapeutic Vaccine
Interventions: Biological: HIV-1 Multiantigen pDNA Vaccine;   Biological: Human IL-12 pDNA;   Procedure: In Vivo Electroporation using the TriGri;   Biological: rVSVIN HIV Gag Vaccine;   Biological: Placebo
11 Recruiting A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2
Conditions: Japanese Encephalitis;   Japanese Encephalitis Vaccine
Intervention: Biological: Live attenuated Japanese encephalitis vaccine SA14-14-2
12 Not yet recruiting Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.
Condition: Measles Vaccine
Intervention: Biological: Early measles vaccine
13 Recruiting Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease
Condition: Tuberculosis Vaccines
Interventions: Biological: GSK Biologicals' investigational TB vaccine GSK 692342;   Biological: Placebo
14 Recruiting Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine
Condition: Poliomyelitis
Interventions: Biological: Bivalent Oral Polio Vaccine (bOPV);   Biological: Trivalent Oral Polio Vaccine (tOPV);   Biological: Monovalent Oral Polio Vaccine Type 2 (mOPV2);   Biological: Sanofi-Pasteur IPV (Sanofi IPV);   Biological: Glaxo SmithKline IPV (GSK IPV);   Biological: Serum Institute of India IPV (SII IPV)
15 Recruiting Immunogenicity of Inactivated and Live Polio Vaccines
Condition: Poliomyelitis
Interventions: Biological: Group A: Trivalent Oral Polio Vaccine;   Biological: Group B: Bivalent Oral Polio Vaccine;   Biological: Group C: Inactivated Polio Vaccine;   Biological: Group D: fractional IPV (f-IPV);   Biological: Arm E: f-IPV and bOPV
16 Not yet recruiting Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya
Conditions: Influenza, Human;   HIV;   Malaria;   Tetanus;   Polio
Interventions: Biological: Trivalent Inactivated Influenza Vaccine;   Biological: Adjuvanted Trivalent Inactivated Influenza Vaccine;   Biological: Inactivated Polio Vaccine
17 Recruiting High Dose Influenza Vaccine in Nursing Homes
Condition: Influenza
Interventions: Biological: HD Vaccine;   Biological: SD Vaccine;   Biological: Free Staff Vaccine;   Biological: No Free Staff Vaccine
18 Recruiting Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen
Condition: Rabies
Interventions: Biological: Purified Vero Rabies Vaccine (VRVg);   Biological: Imovax® Rabies: inactivated rabies vaccine
19 Recruiting Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting
Condition: Influenza
Interventions: Biological: High Dose Inactivated Influenza Vaccine;   Biological: Standard Dose Inactivated Influenza Vaccine
20 Recruiting Understanding the Immune Response to Two Different Meningitis Vaccines
Conditions: Meningitis;   Meningococcal Disease;   Septicaemia
Interventions: Biological: MenACWY-CRM conjugate vaccine (Menveo, Novartis);   Biological: MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis);   Biological: 1/5th dose MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis);   Biological: Polysaccharide (subcutaneously)-conjugate
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years